Thomas Stankovich
Net Worth

Last updated:

What is Thomas Stankovich net worth?

The estimated net worth of Mr. Thomas Stankovich is at least $1,800,600 as of 25 Oct 2023. He owns shares worth $74,355 as insider, has earned $276,245 from insider trading and has received compensation worth at least $1,450,000 in ReShape Lifesciences Inc..

What is the salary of Thomas Stankovich?

Mr. Thomas Stankovich salary is $290,000 per year as Senior Vice President of Fin. & Chief Financial Officer in ReShape Lifesciences Inc..

How old is Thomas Stankovich?

Mr. Thomas Stankovich is 64 years old, born in 1961.

What stocks does Thomas Stankovich currently own?

As insider, Mr. Thomas Stankovich owns shares in one company:

Company Title Shares Price per share Total value
ReShape Lifesciences Inc. (RSLS) Senior Vice President of Fin. & Chief Financial Officer 22,949 $3.24 $74,355

What does ReShape Lifesciences Inc. do?

ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract. It also offers ReShapeCare virtual health coaching program, a virtual telehealth weight management program that supports healthy lifestyle changes for all medically managed weight-loss patients; and ReShape Diabetes Bloc-Stim Neuromodulation, a technology that is in preclinical development for the treatment of type 2 diabetes mellitus. In addition, the company provides Obalon Balloon System, a swallowable capsule used to track and display the location of the balloon during placement. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in San Clemente, California.

RSLS logo
RSLS
ReShape Lifesciences Inc.
$3.24

Thomas Stankovich insider trading

ReShape Lifesciences Inc.

Mr. Thomas Stankovich has made 34 insider trades between 2020-2023, according to the Form 4 filled with the SEC. Most recently he sold 131 units of RSLS stock worth $35 on 25 Oct 2023.

The largest trade he's ever made was exercising 372,744 units of RSLS stock on 22 Jul 2021. As of 25 Oct 2023 he still owns at least 22,949 units of RSLS stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock, $0.001 par value per share 131 $0.27 $35
Sale
Common Stock, $0.001 par value per share 39 $0.93 $36
Sale
Common Stock, $0.001 par value per share 118 $0.89 $105
Sale
Common Stock, $0.001 par value per share 39 $1.42 $55
Sale
Common Stock, $0.001 par value per share 108 $1.43 $154
Sale
Common Stock, $0.001 par value per share 106 $1.47 $156
Purchase
Common Stock, $0.001 par value per share 17,702 $1.52 $26,907
Sale
Common Stock, $0.001 par value per share 98 $2.41 $236
Sale
Common Stock, $0.001 par value per share 96 $2.36 $227
Sale
Common Stock, $0.001 par value per share 109 $2.6 $283
Sale
Common Stock, $0.001 par value per share 103 $4.25 $438
Sale
Common Stock, $0.001 par value per share 157 $13.29 $2,087
Sale
Common Stock, $0.001 par value per share 48 $7.49 $360
Sale
Common Stock, $0.001 par value per share 110 $7.49 $824
Sale
Common Stock, $0.001 par value per share 5,144 $0.15 $777
Sale
Common Stock, $0.001 par value per share 2,213 $0.15 $334
Sale
Common Stock, $0.001 par value per share 364,756 $0.17 $62,009
Sale
Common Stock, $0.001 par value per share 5,883 $0.27 $1,606
Sale
Common Stock, $0.001 par value per share 2,510 $0.27 $683
Sale
Common Stock, $0.001 par value per share 2,484 $0.28 $698
Sale
Common Stock, $0.001 par value per share 5,809 $0.28 $1,632
Sale
Common Stock, $0.001 par value per share 4,828 $0.39 $1,883
Sale
Common Stock, $0.001 par value per share 4,728 $0.47 $2,222
Sale
Common Stock, $0.001 par value per share 4,630 $0.55 $2,547
Sale
Common Stock, $0.001 par value per share 4,478 $0.96 $4,299
Purchase
Common Stock, $0.001 par value per share 1,228 $0.95 $1,167
Purchase
Common Stock, $0.001 par value per share 78 $0.87 $68
Purchase
Common Stock, $0.001 par value per share 2,900 $0.88 $2,552
Purchase
Common Stock, $0.001 par value per share 200 $0.89 $178
Purchase
Common Stock, $0.001 par value per share 1,000 $0.9 $900
Purchase
Common Stock, $0.001 par value per share 7,995 $0.92 $7,355
Purchase
Common Stock, $0.001 par value per share 60 $0.93 $56
Purchase
Common Stock, $0.001 par value per share 6,539 $0.94 $6,147
Sale
Common Stock, $0.001 par value per share 4,529 $0.77 $3,487
Sale
Common Stock, $0.001 par value per share 5,038 $1.13 $5,693
Sale
Common Stock, $0.001 par value per share 3,658 $1.06 $3,877
Sale
Common Stock, $0.001 par value per share 3,684 $1.22 $4,494
Sale
Common Stock, $0.001 par value per share 3,171 $1.78 $5,644
Sale
Common Stock, $0.001 par value per share 4,304 $1.83 $7,863
Purchase
Common Stock, $0.001 par value per share 20,000 $2.02 $40,400
Sale
Common Stock, $0.001 par value per share 4,320 $2.69 $11,621
Sale
Common Stock, $0.001 par value per share 3,660 $2.76 $10,102
Sale
Common Stock, $0.001 par value per share 48,366 $2.89 $139,778
Purchase
Common Stock, $0.001 par value per share 15,000 $3.43 $51,435
Purchase
Common Stock, $0.001 par value per share 15,000 $3.22 $48,285
Sale
Common Stock, $0.001 par value per share 372,744 N/A N/A
Purchase
Common Stock 530 N/A N/A
Purchase
Common Stock 4,105 N/A N/A

ReShape Lifesciences key executives

ReShape Lifesciences Inc. executives and other stock owners filed with the SEC: